Grail (GRAL) announced a new partnership with athenahealth. This collaboration will integrate ordering of Grail’s Galleri multi-cancer early detection test into athenaCoordinator Core, a service designed to help streamline laboratory order transmission and care coordination for healthcare facilities. The integration will be provided through athenaOne, athenahealth’s leading cloud-based electronic health record solution. Integration with athenaCoordinator Core will allow over 160,000 U.S. clinicians on the athenahealth network to opt in to more seamlessly order Galleri directly in the EHR, reducing additional ordering steps. After the clinician’s order is placed, the patient can take the Galleri test kit to a blood draw appointment. The Galleri test results will be made available automatically in the patient chart, reducing manual entry and administrative burden for the clinician’s practice.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRAL:
